$1.80 7.7%
ARAY Stock Price vs. AI Score (Last 150 days)
Data gathered: July 18

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region.


Accuray
Price $1.80
Target Price Sign up
Volume 730,060
Market Cap $205M
Year Range $1.49 - $3.01
Dividend Yield 0%
Revenue per Employee $412,408
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24101M72M29M-6.3M-3M-0.060
Q4 '23107M71M36M-9.6M-3M-0.100
Q3 '23104M64M39M-3M4.1M-0.030
Q2 '23118M81M38M-2.6M-460,000-0.030
Q1 '23118M79M39M600,0002.3M0.010

Insider Transactions View All

Pervaiz Ali filed to sell 402,542 shares at $1.7.
June 6 '24
WHITTERS JOSEPH E filed to buy 561,053 shares at $1.6.
May 30 '24
Hoge Michael filed to sell 390,208 shares at $2.6.
March 5 '24
Pervaiz Ali filed to sell 402,743 shares at $2.7.
January 5 '24
Corradetti GIna filed to sell 196,138 shares at $2.7.
January 5 '24

What is the Market Cap of Accuray?

The Market Cap of Accuray is $205M.

How Many People Work at Accuray?

As of our latest update, Accuray employed approximately 1,044 people worldwide. However, it's important to note that Accuray's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Accuray's revenue per employee?

$412,408. To calculate Accuray's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Accuray?

Currently, the price of one share of Accuray stock is $1.80.

How can I analyze the ARAY stock price chart for investment decisions?

The ARAY stock price chart above provides a comprehensive visual representation of Accuray's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Accuray shares. Our platform offers an up-to-date ARAY stock price chart, along with technical data analysis and alternative data insights.

Does ARAY offer dividends to its shareholders?

As of our latest update, Accuray (ARAY) does not offer dividends to its shareholders. Investors interested in Accuray should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Accuray?

Some of the similar stocks of Accuray are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.